Letter commenting on the article "CA 125 expression pattern, prognosis and correlation with serum CA 125 in ovarian tumor patients" (104:508-515) by Hogdall, et al and on the Editorial "CA 125: megadaltons of novel opportunities" (104:505-507)

Gynecol Oncol. 2007 Nov;107(2):355-6. doi: 10.1016/j.ygyno.2007.07.055. Epub 2007 Aug 20.

Authors

Anne M van Altena, Joanne A de Hullu, Leon F A G Massuger

PMID: 17707896
DOI: 10.1016/j.ygyno.2007.07.055

No abstract available

Publication types

Comment
Letter

MeSH terms

Biomarkers, Tumor / blood*
CA-125 Antigen / blood*
Female
Gene Expression Regulation, Neoplastic
Humans
Ovarian Neoplasms / blood*
Ovarian Neoplasms / mortality
Predictive Value of Tests
Prognosis
Survival Analysis

Substances

Biomarkers, Tumor
CA-125 Antigen